Aprameya Engineering Ltd
Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]
- Market Cap ₹ 623 Cr.
- Current Price ₹ 327
- High / Low ₹ 360 / 86.5
- Stock P/E 25.3
- Book Value ₹ 37.3
- Dividend Yield 0.00 %
- ROCE 31.1 %
- ROE 36.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 90.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.2%
Cons
- Stock is trading at 8.54 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 320 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 12 | 26 | 35 | 78 | 65 | 136 | 169 | |
| 11 | 24 | 25 | 69 | 59 | 111 | 132 | |
| Operating Profit | 2 | 2 | 10 | 9 | 6 | 24 | 37 |
| OPM % | 13% | 9% | 29% | 12% | 10% | 18% | 22% |
| 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
| Interest | 1 | 1 | 0 | 2 | 2 | 3 | 4 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 2 | 10 | 7 | 5 | 22 | 33 |
| Tax % | 8% | 44% | 25% | 28% | 24% | 26% | |
| 1 | 1 | 7 | 5 | 3 | 16 | 25 | |
| EPS in Rs | 10.66 | 3.84 | 2.49 | 8.47 | 12.92 | ||
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 62% |
| 3 Years: | 57% |
| TTM: | 108% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 90% |
| 3 Years: | 29% |
| TTM: | 362% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 265% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 30% |
| Last Year: | 37% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 7 | 14 | 14 | 19 | 19 |
| Reserves | -0 | -0 | 7 | 6 | 9 | 45 | 52 |
| 4 | 1 | 14 | 29 | 42 | 30 | 37 | |
| 6 | 5 | 20 | 13 | 10 | 49 | 26 | |
| Total Liabilities | 14 | 11 | 49 | 62 | 76 | 144 | 135 |
| 1 | 1 | 2 | 1 | 1 | 1 | 1 | |
| CWIP | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Investments | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| 13 | 10 | 47 | 60 | 74 | 143 | 133 | |
| Total Assets | 14 | 11 | 49 | 62 | 76 | 144 | 135 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 0 | 4 | 10 | -13 | -10 | -11 | |
| -1 | 0 | -0 | -2 | -1 | -0 | |
| 1 | -4 | -8 | 13 | 11 | 11 | |
| Net Cash Flow | 0 | -0 | 2 | -2 | 0 | -0 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 182 | 58 | 278 | 195 | 325 | 320 |
| Inventory Days | 245 | 122 | 455 | 376 | 74 | |
| Days Payable | 269 | 147 | 1,100 | 415 | 146 | |
| Cash Conversion Cycle | 159 | 33 | -367 | 157 | 253 | 320 |
| Working Capital Days | 40 | 36 | 200 | 116 | 153 | 166 |
| ROCE % | 35% | 59% | 25% | 12% | 31% |
Documents
Announcements
-
Analysts/Institutional Investor Meet/Con. Call Updates
1 December 2025 - Participating virtually in SAMRUDHI 2.0 SME Conclave on 3 Dec 2025, 3:00 PM.
-
Analysts/Institutional Investor Meet/Con. Call Updates
27 November 2025 - Investor meeting on Dec 2, 2025 at Emerging Ideas Conference 2025; presentation public.
-
Analysts/Institutional Investor Meet/Con. Call Updates
24 November 2025 - Aprameya to attend SAMRUDHI 2.0 virtual SME conclave on 3 Dec 2025, 3:00 PM.
-
Analysts/Institutional Investor Meet/Con. Call Updates
16 November 2025 - Uploaded earnings call transcript (Nov 14, 2025) and H2/FY25 audio (May 13, 2025).
-
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
15 November 2025 - GST notice blocked ITC Rs45,75,930 (IGST Rs39,56,846; CGST Rs3,09,272; SGST Rs3,09,272); company pursuing legal remedies.
Annual reports
Concalls
-
Nov 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
Business Segments
A) Healthcare Infrastructure Projects[1][2]
The company offers turnkey solutions for developing healthcare facilities, covering everything from design to execution of ICUs, NICUs, PICUs, Modular Operation Theatres (MOTs), Dialysis Centers, and Prefabricated Wards. The scope also includes integration of MEP systems, fire safety, structural design, and hospital interiors. These projects are tailored for public healthcare institutions, focused on customized infrastructure delivery.